Genetically engineered lymphocyte therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically engineered lymphocyte therapy, covering 2015-09-29 to 2015-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]